Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C20H18FN3O5 |
Molecular Weight | 399.3724 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 1 / 1 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CNC(=O)C[C@H]1COC2=C(C=CC(F)=C2)N1C(=O)C3=CC4=C(OCC(=O)N4)C=C3
InChI
InChIKey=MBKYLPOPYYLTNW-ZDUSSCGKSA-N
InChI=1S/C20H18FN3O5/c1-22-18(25)8-13-9-28-17-7-12(21)3-4-15(17)24(13)20(27)11-2-5-16-14(6-11)23-19(26)10-29-16/h2-7,13H,8-10H2,1H3,(H,22,25)(H,23,26)/t13-/m0/s1
Molecular Formula | C20H18FN3O5 |
Molecular Weight | 399.3724 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 1 / 1 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 15:07:55 GMT 2023
by
admin
on
Sat Dec 16 15:07:55 GMT 2023
|
Record UNII |
6C9UKZ0CYE
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Code | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
118599727
Created by
admin on Sat Dec 16 15:07:56 GMT 2023 , Edited by admin on Sat Dec 16 15:07:56 GMT 2023
|
PRIMARY | |||
|
1850385-64-6
Created by
admin on Sat Dec 16 15:07:56 GMT 2023 , Edited by admin on Sat Dec 16 15:07:56 GMT 2023
|
PRIMARY | |||
|
DB15418
Created by
admin on Sat Dec 16 15:07:56 GMT 2023 , Edited by admin on Sat Dec 16 15:07:56 GMT 2023
|
PRIMARY | |||
|
300000026951
Created by
admin on Sat Dec 16 15:07:56 GMT 2023 , Edited by admin on Sat Dec 16 15:07:56 GMT 2023
|
PRIMARY | |||
|
11980
Created by
admin on Sat Dec 16 15:07:56 GMT 2023 , Edited by admin on Sat Dec 16 15:07:56 GMT 2023
|
PRIMARY | |||
|
C188521
Created by
admin on Sat Dec 16 15:07:56 GMT 2023 , Edited by admin on Sat Dec 16 15:07:56 GMT 2023
|
PRIMARY | |||
|
6C9UKZ0CYE
Created by
admin on Sat Dec 16 15:07:56 GMT 2023 , Edited by admin on Sat Dec 16 15:07:56 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
TARGET->PARTIAL ANTAGONIST |
AZD9977 is a partial MR antagonist due to its unique interaction pattern with MR, which results in a distinct recruitment of co-factor peptides when compared to eplerenone. AZD9977 dose dependently reduced albuminuria and improved kidney histopathology similar to eplerenone in db/db uni-nephrectomised mice and uni-nephrectomised rats. In acute testing, AZD9977 did not affect urinary Na+/K+ ratio
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
|